Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism
出版年份 2016 全文链接
标题
Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-09-19
DOI
10.1038/srep33302
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Blockade of cannabinoid 1 receptor improves GLP-1R mediated insulin secretion in mice
- (2016) Isabel González-Mariscal et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Development and preliminary validation of a plate-based CB1/CB2 receptor functional assay
- (2013) K.S.S. Dossou et al. ANALYTICAL BIOCHEMISTRY
- Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice
- (2013) A M McKillop et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders
- (2013) Cristoforo Silvestri et al. Cell Metabolism
- Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain ceramides
- (2013) Resat Cinar et al. HEPATOLOGY
- CB1Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release
- (2013) Katarzyna Malenczyk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Detection of molecular alterations in methamphetamine-activated Fos-expressing neurons from a single rat dorsal striatum using fluorescence-activated cell sorting (FACS)
- (2013) Qing-Rong Liu et al. JOURNAL OF NEUROCHEMISTRY
- Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
- (2013) Tony Jourdan et al. NATURE MEDICINE
- JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities
- (2012) Robert J. Chorvat et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- Chronic activation of cannabinoid receptorsin vitrodoes not compromise mouse islet function
- (2012) Alonso Vilches-Flores et al. CLINICAL SCIENCE
- The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55
- (2012) Julia Kargl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening
- (2011) R. Moaddel et al. ANALYTICAL BIOCHEMISTRY
- Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones
- (2011) Alex Straiker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic -Cells
- (2011) W. Kim et al. DIABETES
- Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans
- (2011) C. Li et al. DIABETES OBESITY & METABOLISM
- Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions
- (2011) Patricia Rivera et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
- (2011) Silvana Y Romero-Zerbo et al. JOURNAL OF ENDOCRINOLOGY
- Detailed protocol for evaluation of dynamic perifusion of human islets to assess β-cell function
- (2011) Kwamina Bentsi-Barnes et al. Islets
- Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells
- (2010) Chen Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of the pancreatic endocannabinoid system in glucose metabolism
- (2009) Francisco J. Bermúdez-Silva et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
- (2009) Fabrício A. Moreira et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients
- (2009) Riccardo Sarzani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The cannabinoid CB1 receptor is expressed in pancreatic δ-cells
- (2008) William G. Tharp et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells
- (2008) Jing Chen Xiao et al. BRAIN RESEARCH
- Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats
- (2008) R. Nogueiras et al. DIABETES
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
- (2008) Douglas Osei-Hyiaman et al. JOURNAL OF CLINICAL INVESTIGATION
- Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!
- (2008) Natasha L. Grimsey et al. JOURNAL OF NEUROSCIENCE METHODS
- Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet
- (2008) Katarzyna M. Starowicz et al. Obesity
- Isolation of major pancreatic cell types and long-term culture-initiating cells using novel human surface markers
- (2008) Craig Dorrell et al. Stem Cell Research
- Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet β-cells via CB1 receptors
- (2007) Masanori Nakata et al. REGULATORY PEPTIDES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now